MARKET RADAR
SENSEX     NIFTY      
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
AstraZeneca Pharma
BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 17:00
1689.70
-7.75 (-0.46%)
VOLUME 119
LIVE
NSE
Feb 10, 17:00
1678.95
-9.95 (-0.59%)
VOLUME 1,531
Announcements on AstraZeneca

6th-Feb-2012 15:42Source: NSE

AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2011.

2nd-Feb-2012 17:24Source: BSE

AstraZeneca- Financial Results & Limited Review for Dec 31, 2011

AstraZeneca Pharma India Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2011.

25th-Jan-2012 07:35Source: NSE

AstraZeneca Pharma India Limited

Astrazeneca Pharma India Limited has informed the Exchange that Mr. Raghunath Rath, Company Secretary and Compliance Officer of the Company ceased to be so w.e.f. closure of business hour on January 0...

23rd-Jan-2012 18:20Source: BSE

AstraZeneca- Cessation of Company Secretary & Compliance Officer

AstraZeneca Pharma India Ltd has informed BSE that Mr. Raghunath Rath, Company Secretary and Compliance Officer of the Company ceased to be so w.e.f. closure of business hour on January 04, 2012.
<...

15th-Dec-2011 15:41Source: NSE

AstraZeneca Pharma India Limited

Astrazeneca Pharma India Limited has informed the Exchange that the Board in its meeting held on November 10, 2011, appointed Ms. Ruby Lau as a Whole Time Director of the Company for a period of 2(two...

11th-Nov-2011 11:25Source: NSE

AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

11th-Nov-2011 09:50Source: NSE

AstraZeneca Pharma India Limited

Astrazeneca Pharma India Limited has informed the Exchange that at the Board Meeting of the Company held on November 10, 2011, the Directors approved the following: (1) Ms. Ruby Lau, VP-Operations was...

11th-Nov-2011 09:22Source: BSE

AstraZeneca- Outcome of Board Meeting

AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 10, 2011, has approved the following:

- Ms. Ruby Lau, VP-Operations was...

10th-Nov-2011 18:46Source: BSE

AstraZeneca- Financial Results for Sep 30, 2011

AstraZeneca Pharma India Ltd has informed BSE about the Financial Results for the period ended September 30, 2011.

4th-Oct-2011 18:30Source: NSE

AstraZeneca Pharma India Limited-Updates

Astrazeneca Pharma India Limited has informed the Exchange that the Board in its meeting held on September 14, 2011, re-appointed Mr. Anandh Balasundaram as the Managing Director of the Company for a ...

1 2 3 4 5 Next >>
Quick Links for AstraZeneca Pharma
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.